To the Editor,
The most common mechanisms for resistance in patients with chronic myeloid leukemia (CML) receiving imatinib mesylate are BCR-ABL kinase domain (KD) mutations. The mutations are stratifi ed according to i...
Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
EP ID EP127194
DOI 10.4274/Tjh.2013.0127
Views 73
Downloads 0
How To Cite
Muhammed Mubarak, Hamid Nasri (2013). Antiphospholipid Antibodies and Systemic Scleroderma. Turkish Journal of Hematology, 30(4),
429-430. https://europub.co.uk/articles/-A-127194
Sign In Europub
For faster login or register use your social account.
t(9;19)(q22;p13) in Acute Myelomonocytic Leukemia
.
Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
To the Editor, The most common mechanisms for resistance in patients with chronic myeloid leukemia (CML) receiving imatinib mesylate are BCR-ABL kinase domain (KD) mutations. The mutations are stratifi ed according to i...
Turkish Journal of Hematology: From “Istanbul Contribution to Clinical Science” to “Pubmed Central”
Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients